except
rabi
vaccin
introduc
earlier
centuri
efficaci
canin
vaccin
protect
infecti
diseas
develop
past
year
research
develop
time
period
focus
control
fatal
infecti
diseas
like
canin
distemp
infecti
canin
hepat
canin
parvoviru
infect
leptospirosi
later
develop
address
need
control
nonfat
diseas
kennel
cough
lyme
diseas
modifi
live
viru
mlv
vaccin
becam
product
choic
control
fatal
viru
infect
dog
induc
rapid
prolong
cellular
well
humor
immun
respons
singl
inocul
suscept
anim
histor
inactiv
kill
viru
vaccin
suffici
control
diseas
induc
canin
distemp
viru
cdv
canin
parvoviru
cpv
inactiv
viru
vaccin
success
develop
prevent
rabi
viru
infect
inactiv
bacteri
product
bacterin
protect
dog
certain
strain
leptospirosi
bordetella
bronchiseptica
borrelia
burgdorferi
lyme
diseas
induct
mucos
immun
intranas
inocul
modifi
live
product
provid
better
protect
infecti
agent
caus
kennel
cough
parenter
inocul
inactiv
product
recombin
vaccin
canin
distemp
introduc
recent
may
begin
new
era
vaccin
product
intend
increas
safeti
level
vaccin
howev
efficaci
vaccin
probabl
compar
mlv
vaccin
recombin
vaccin
expect
appear
market
undoubtedli
dna
vaccin
introduc
canin
infecti
diseas
may
similar
effect
case
vaccin
product
enhanc
one
factor
come
sacrific
present
tendenc
produc
safer
product
question
remain
whether
safer
product
suffici
control
diseas
outbreak
appear
canin
infecti
diseas
present
control
well
vaccin
may
time
fine
tune
address
lesser
problem
possibl
autoimmun
respons
breed
multipl
vaccin
question
rais
vaccin
much
answer
probabl
ye
limit
data
avail
durat
vaccineinduc
immun
cdv
cpv
canin
adenoviru
cav
dog
kept
isol
immun
diseas
last
sever
year
annual
revaccin
may
unwarr
addit
reliabl
afford
quick
test
level
matern
antibodi
becom
avail
multipl
puppi
vaccin
could
reduc
one
two
inocul
use
oronas
vaccin
could
develop
product
perhap
combin
newli
develop
vector
may
reduc
risk
abnorm
reaction
needl
inocul
addit
innov
reduc
risk
vaccin
maintain
protect
anim
purpos
paper
give
brief
histor
review
canin
vaccin
develop
past
year
rabi
dog
known
sinc
fifth
centuri
bc
dog
long
known
princip
transmitt
rabi
first
rabi
vaccin
develop
pasteur
earli
adapt
street
viru
rabbit
serial
intracerebr
passag
pasteur
pasteur
vaccin
predominantli
use
human
vaccin
chloroform
ether
inactiv
viru
vaccin
dog
prepar
infect
brain
suspens
becam
avail
kelser
develop
live
attenu
rabi
viru
vaccin
low
egg
passag
lep
high
egg
passag
hep
koprowski
led
effect
vaccin
dog
tierkel
et
al
sike
howev
rare
occas
live
attenu
vaccin
caus
rabieslik
diseas
dog
longer
avail
greatli
improv
inactiv
viru
vaccin
prepar
rabi
viru
grown
diploid
cell
cultur
commonli
use
dog
pastoret
et
al
although
antigen
differ
viru
strain
found
monoclon
antibodi
vaccin
crossprotect
differ
strain
wiktor
koprowski
inactiv
rabi
viru
vaccin
market
today
induc
immun
dog
last
year
promis
result
report
rabi
iscom
osterhau
et
al
addit
newer
develop
includ
viral
vector
express
rabi
viru
g
protein
vector
nonrepl
mammalian
host
avipox
virus
fowlpox
canarypox
recombin
rabi
vaccin
induc
protect
immun
dog
prove
safe
taylor
et
al
taylor
et
al
sever
countri
around
world
canin
rabi
greatli
reduc
mass
immun
dog
bsgel
et
al
great
reduct
wildlif
rabi
sourc
dog
rabi
accomplish
introduct
live
attenu
rabi
viru
oral
rout
baer
et
al
initi
mlv
vaccin
appli
later
replac
vaccinia
recombin
rabi
vaccin
pastoret
et
al
result
oral
vaccin
dog
remain
inconclus
canin
distemp
cd
caus
morbilliviru
close
relat
measl
rinderpest
virus
first
vaccin
cd
made
puntoni
formalin
inactiv
brain
tissu
dog
distemp
enceph
inactiv
cdv
vaccin
use
earlier
centuri
abl
control
diseas
longer
commerci
avail
unit
state
includ
limit
protect
diseas
protect
infect
anoth
approach
attempt
laidlaw
dunkin
late
simultan
inocul
virul
viru
antiserum
result
satisfactori
vaccin
heterotyp
measl
viru
mv
induc
protect
diseas
infect
cdv
appel
et
al
advantag
induc
partial
immun
pup
matern
antibodi
review
appel
gillespi
first
mlv
vaccin
cd
develop
green
carlson
passag
viru
time
ferret
vaccin
wide
use
unfortun
clinic
sign
death
frequent
occur
vaccin
mlv
vaccin
cd
control
diseas
still
use
today
develop
late
viru
adapt
embryon
hen
egg
cabasso
cox
lederl
strain
haig
onderstepoort
strain
strain
later
adapt
tissu
cultur
rockborn
introduc
canin
kidney
cell
cultur
adapt
cdv
vaccin
still
use
worldwid
today
advantag
disadvantag
type
vaccin
rockborn
vaccin
induc
complet
immun
virtual
suscept
dog
howev
product
compani
induc
postvaccin
enceph
pve
seen
year
origin
authent
product
behringwerk
hoechst
germani
onderstepoort
strain
doesnot
induc
pve
howev
seroconvers
rate
product
gener
lower
h
glycoprotein
profil
differ
h
protein
field
isol
harder
et
al
promis
approach
taken
de
vri
et
al
incorpor
cdvh
f
protein
immun
stimul
complex
iscom
protect
dog
cdv
infect
h
f
protein
import
produc
immun
cdv
futur
recombin
dna
vaccin
incorpor
recombin
cdv
vaccin
contain
h
f
gene
canarypox
viru
carrier
introduc
stephensen
et
al
new
enter
diseas
dog
resembl
panleukopenia
cat
mink
enter
appear
north
america
europ
australia
parvoviru
isol
appel
et
al
tent
classifi
canin
parvoviru
type
carmichael
binn
contrast
minut
viru
canin
isol
refer
canin
parvoviru
type
believ
mutant
felin
panleukopenia
viru
fpv
mink
enter
viru
howev
origin
new
viru
remain
unknown
soon
detect
inactiv
heterotyp
fpv
vaccin
introduc
control
diseas
limit
extent
appel
et
al
pollock
carmichael
vaccin
becam
avail
pollock
carmichael
safe
efficaci
inactiv
heterotyp
vaccin
vaccin
protect
dog
infect
well
diseas
antibodi
titer
test
consid
protect
dog
vaccin
vaccin
kept
isol
thereaft
protect
antibodi
titer
least
year
vaccin
l
e
carmichael
person
commun
mutat
new
vaccin
introduc
parrish
howev
origin
vaccin
protect
dog
present
field
strain
appel
carmichael
vaccin
failur
frequent
found
matern
antibodi
interfer
immun
pup
becom
suscept
virul
suscept
vaccin
window
suscept
may
last
week
pollock
although
claim
vaccin
produc
none
present
avail
vaccin
elimin
window
entir
canin
coronaviru
ccv
caus
mild
gastroenter
dog
appel
et
al
carmichael
binn
howev
may
enhanc
pathogen
infect
appel
viru
first
isol
sentri
dog
diarrhea
binn
et
al
distribut
viru
dog
appear
worldwid
pensaert
callebaut
rimmelzwaan
inactiv
ccv
vaccin
introduc
edward
et
al
vaccin
protect
dog
diseas
infect
mild
natur
diseas
limit
protect
kill
vaccin
use
dog
debat
mlccv
vaccin
introduc
combin
canin
vaccin
includ
cpv
cdv
vaccin
withdrawn
market
month
later
advers
reaction
seen
dog
central
nervou
sign
death
dog
martin
wilson
et
al
differ
strain
mlccv
recent
licens
unit
state
appear
safe
efficaci
howev
combin
mlcdv
rockborn
strain
produc
pve
larg
number
dog
combin
withdrawn
market
replac
mlccv
canarypox
vector
cdv
incap
caus
pve
ml
felin
enter
coronaviru
vaccin
antigen
relat
ccv
also
becam
avail
recent
infecti
canin
hepat
ich
hepat
contagi
cani
hcc
formerli
known
epizoot
fox
enceph
caus
canin
adenoviru
type
comprehens
report
diseas
dog
made
rubarth
besid
acut
hepat
known
respons
diseas
eg
encephalopathi
neonat
diseas
respiratori
diseas
chronic
hepat
interstiti
nephriti
ocular
lesion
review
koptopoulo
cornwel
viru
isol
product
mlv
vaccin
follow
serial
passag
dog
swine
cell
cabasso
et
al
cabasso
et
al
safeti
product
limit
vaccin
induc
blue
eye
dog
shed
urin
produc
kidney
lesion
vaccin
control
ich
replac
vaccin
induc
protect
ich
viru
infect
without
undesir
side
effect
vaccin
appel
et
al
inactiv
vaccin
market
unit
state
editor
note
vaccin
manufactur
bayer
anim
health
previous
biocor
previous
tech
america
still
contain
inactiv
compon
accord
packag
insert
also
contain
inactiv
avail
countri
found
safe
efficaci
limit
time
period
miller
et
al
viru
design
toronto
isol
ditchfield
et
al
dog
canada
suffer
laryngotrach
kennel
cough
viru
one
agent
caus
sever
kennel
cough
nonvaccin
puppi
pet
shop
situat
may
simul
canin
distemp
appel
found
antigen
relat
howev
tissu
tropism
virus
entir
differ
appel
et
al
viru
later
classifi
hamelin
et
al
marusyk
et
al
attenu
prove
protect
dog
infect
appel
et
al
vaccin
safer
vaccin
former
replac
latter
intranas
vaccin
avail
combin
b
bronchiseptica
canin
parainfluenza
viru
protect
dog
kennel
cough
advantag
parenter
inject
induc
immun
pup
matern
antibodi
appel
et
al
therefor
one
inocul
need
canin
parainfluenza
viru
cpiv
one
main
caus
canin
infecti
tracheobronch
kennel
cough
worldwid
distribut
appel
perci
viru
first
isol
laboratori
dog
respiratori
diseas
binn
et
al
cpiv
close
relat
simian
viru
binn
et
al
crandel
et
al
human
parainfluenza
hsiung
attenu
cpiv
vaccin
introduc
combin
b
bronchiseptica
two
form
one
inactiv
b
bronchiseptica
parenter
inocul
chladek
et
al
emeri
et
al
one
ml
b
bronchiseptica
intranas
inocul
glickman
appel
kontor
et
al
protect
infect
agent
depend
mucos
immun
iga
product
latter
protect
infect
diseas
former
protect
diseas
addit
matern
antibodi
interfer
intranas
applic
recent
compon
ad
intranas
vaccin
also
involv
kennel
cough
complex
genom
analysi
virul
attenu
strain
cpiv
made
yonezawa
although
cpiv
vaccineinduc
immun
probabl
last
longer
year
annual
revaccin
combin
vaccin
recommend
immun
b
bronchiseptica
limit
bordetella
bronchiseptica
main
caus
canin
infecti
tracheobronch
kennel
cough
highli
contagi
respiratori
diseas
dog
bemi
et
al
binn
et
al
wagen
et
al
wright
et
al
infect
b
bronchiseptica
restrict
dog
varieti
speci
becom
infect
agent
includ
pig
cat
rodent
although
b
bronchiseptica
highli
suscept
antibiot
vitro
vivo
effect
limit
organ
attach
cilia
trachea
bronchi
bemi
appel
bemi
et
al
immun
respons
b
bronchiseptica
dog
slow
although
dog
becom
resist
reinfect
clearanc
initi
week
infect
total
clearanc
bronchial
tree
take
month
bemi
et
al
mucos
immun
result
infect
intranas
vaccin
last
year
bemi
et
al
muscos
immun
iga
product
essenti
protect
infect
cpiv
two
form
vaccin
develop
one
inactiv
bacterin
adjuv
parenter
inocul
chladek
et
al
mccandlish
thompson
one
ml
combin
cpiv
intranas
instal
bey
et
al
glickman
appel
kontor
et
al
shade
goodnow
latter
protect
infect
virul
b
bronchiseptica
diseas
former
protect
diseas
two
inocul
suscept
pup
need
induc
protect
matern
antibodi
interfer
intranas
vaccin
one
inocul
need
addit
parenter
inocul
kill
organ
adjuv
may
caus
undesir
local
reaction
lyme
diseas
lyme
borreliosi
caus
spirochet
borrelia
burgdorferi
barbour
agent
transmit
hard
shell
tick
ixod
speci
spach
et
al
appel
lyme
diseas
seen
human
steer
dog
appel
et
al
levi
et
al
cat
may
et
al
hors
cattl
parker
white
natur
infect
diseas
human
north
american
contin
first
describ
steer
et
al
dog
lissman
et
al
vaccin
strategi
taken
consider
lyme
diseas
unit
state
caus
b
burgdorferi
sensu
stricto
addit
strain
b
garinii
b
afzelii
b
japonica
known
occur
worldwid
crossprotect
strain
limit
lovrich
et
al
addit
lyme
diseas
promin
endem
area
nineti
percent
lyme
diseas
unit
state
found
northeast
upper
mississippi
region
northern
california
follow
frequenc
vaccin
dog
recommend
endem
area
dog
expos
tick
comment
seroposit
dog
develop
clinic
lame
respond
well
antibiot
treatment
howev
high
percentag
expos
nonlam
dog
subclin
chronic
polyarthr
appel
et
al
antibiot
treatment
entir
elimin
persist
infect
straubing
et
al
b
addit
fatal
renal
syndrom
observ
limit
number
dog
dambach
et
al
wholecel
bacterin
dog
introduc
chu
et
al
singl
protein
vaccin
dog
prepar
recombin
outer
surfac
protein
b
burgdorferi
becam
avail
et
al
chang
et
al
ospa
vaccin
advantag
induc
specif
borreliacid
antibodi
dog
speci
prevent
transmiss
b
burgdorferi
tick
dog
ospa
vaccin
human
lyme
diseas
test
stage
editor
note
extens
research
attempt
demonstr
infect
diseas
b
burgdorferi
cattl
calv
fetus
utero
adult
pregnant
cow
schultz
other
show
cattl
highli
resist
infect
clinic
diseas
produc
age
anim
includ
young
fetus
multipl
isol
b
burgdorferi
given
low
high
dose
leptospirosi
zoonot
diseas
worldwid
distribut
diseas
may
fatal
dog
left
untreat
hartman
et
al
dog
may
recov
clinic
antibiot
treatment
may
die
kidney
failur
uremia
sever
month
year
later
diseas
caus
infect
antigen
distinct
serovar
leptospira
common
serovar
isol
dog
use
l
icterohaemorrhagia
l
canicola
l
pomona
l
grippotyphosa
howev
recent
year
outbreak
leptospirosi
dog
infect
differ
serovar
report
canada
long
island
raccoon
opossum
deer
rodent
domest
livestock
reservoir
l
serovar
except
l
canicola
transmit
dog
dog
bival
bacterin
dog
contain
l
canicola
l
icterohaemorrhagia
market
sinc
hartman
et
al
b
prepar
chemic
inactiv
whole
cell
make
rel
allergen
immun
vaccin
highli
serovar
specif
immun
dog
protect
type
common
mani
area
may
infect
dog
may
also
suppress
immun
respons
young
puppi
vaccin
pup
less
week
age
recommend
addit
vaccineinduc
immun
dog
often
less
month
repeat
vaccin
endem
area
would
essenti
protect
broughton
scarnel
would
highli
desir
specif
outer
surfac
envelop
protein
immun
dog
bey
johnson
like
ospa
vaccin
lyme
diseas
anoth
spirochet
diseas
reduc
risk
anaphylact
shock
vaccinerel
disord
addit
serovar
includ
leptospira
vaccin
correl
serovar
endem
area
public
health
consider
leptospiracontamin
urin
highli
infecti
peopl
persist
infect
healthi
vaccin
dog
leptospiruria
found
result
develop
diseas
peopl
feigin
et
al
last
year
vaccin
develop
greatli
reduc
incid
infecti
diseas
dog
gener
modifi
live
product
superior
inactiv
vaccin
dog
expect
recombin
andor
dna
vaccin
may
domin
market
futur
although
vaccin
market
safe
efficaci
except
diseas
induc
vaccin
dog
protect
failur
protect
may
part
due
variat
individu
vaccin
batch
potenc
test
efficaci
test
requir
may
suffici
exampl
viru
titer
vaccin
may
meaningless
minimum
protect
dose
known
overattenu
viru
eg
cdvond
parvoviru
cat
cell
may
high
titer
tissu
cultur
immunogen
question
frequenc
vaccin
dog
address
annual
revaccin
cdv
cpv
cav
probabl
need
howev
would
desir
collect
data
support
less
frequent
vaccin
annual
immun
bacteri
diseas
kennel
cough
lyme
diseas
leptospirosi
continu
also
would
desir
develop
oronas
vaccin
perhap
combin
newli
develop
vector
less
like
induc
undesir
side
effect
may
seen
parenter
vaccin
final
word
warn
homeopath
nosod
replac
test
canin
vaccin
appear
highli
effect
long
major
dog
remain
vaccin
soon
nonvaccin
dog
popul
larg
enough
allow
virul
agent
spread
diseas
outbreak
occur
back
began
year
ago
